The FDA's concerns cite peptide manufacturing risks: incompletely characterised active ingredient, peptide fragments, degradation products, and impurities that the immune system may recognise as foreign
Abstract Introduction: Previous meta-analyses investigating the therapeutic effects of L-carnitine on lipid profiles have demonstrated inconsistent results
Include a Letter of Medical Necessity from your Kaiser prescriber citing STEP 1 (Wilding et al
I think we should let patients explain how impactful those adverse effects were
Nucleic Acids Res 52(16):96309653 Noseda R, Burstein R (2013) Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain
To begin, youll consult with a licensed healthcare provider